News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,224 Results
Type
Article (2593)
Company Profile (45)
Press Release (37585)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14205)
Career Advice (79)
Deals (2111)
Drug Delivery (9)
Drug Development (4146)
Employer Resources (10)
FDA (444)
Job Trends (783)
News (20297)
Policy (1063)
Tag
Academia (145)
Allergies (7)
Alliances (3497)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (447)
Artificial intelligence (31)
Autoimmune disease (9)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (17)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (331)
Cardiovascular disease (10)
Career advice (67)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (84)
Cervical cancer (2)
Clinical research (3444)
Collaboration (201)
Company closure (2)
Compensation (105)
COVID-19 (185)
CRISPR (11)
C-suite (114)
Cystic fibrosis (7)
Data (424)
Denatured (6)
Depression (11)
Diabetes (18)
Diagnostics (492)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (44)
Earnings (4519)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6420)
Executive appointments (135)
FDA (592)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (57)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (709)
HIV (2)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (5)
Infectious disease (198)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (26)
Interviews (8)
IPO (1004)
IRA (7)
Job creations (294)
Job search strategy (63)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (52)
Leadership (3)
Legal (218)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1225)
Metabolic disorders (73)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (353)
Non-profit (157)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (20)
Pain (24)
Pancreatic cancer (22)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (28)
Peanut (1)
People (5880)
Pharmaceutical (5)
Phase 1 (1478)
Phase 2 (1705)
Phase 3 (916)
Pipeline (407)
Policy (16)
Postmarket research (30)
Preclinical (641)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (63)
Real estate (425)
Recruiting (5)
Regulatory (924)
Reports (7)
Research institute (150)
Resumes & cover letters (10)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (499)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (13)
Last 7 days (56)
Last 30 days (160)
Last 365 days (2450)
2026 (263)
2025 (2443)
2024 (2616)
2023 (2861)
2022 (3756)
2021 (4060)
2020 (3479)
2019 (2065)
2018 (1559)
2017 (1799)
2016 (1627)
2015 (1836)
2014 (1372)
2013 (1190)
2012 (1398)
2011 (1333)
2010 (1184)
Location
Africa (45)
Alabama (3)
Alaska (1)
Arizona (18)
Asia (1955)
Australia (308)
California (1620)
Canada (249)
China (82)
Colorado (55)
Connecticut (16)
Delaware (5)
Europe (4026)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (61)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (576)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (137)
New York (81)
North Carolina (133)
Northern California (791)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (113)
Puerto Rico (1)
Rhode Island (2)
South America (41)
South Carolina (1)
Southern California (662)
Tennessee (5)
Texas (153)
United States (3246)
Utah (5)
Virginia (12)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,224 Results for "mammoth biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
1 min read
Press Releases
VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology
September 9, 2025
·
3 min read
Press Releases
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
October 1, 2025
·
3 min read
Biotech Bay
Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy
Mammoth Biosciences today announced that Lucas Harrington, Ph.D., Mammoth’s co-founder and Chief Scientific Officer, will present new preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, May 7 - 11, 2024.
May 2, 2024
·
3 min read
Press Releases
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
May 5, 2025
·
4 min read
Press Releases
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
May 1, 2025
·
2 min read
Business
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Mammoth Biosciences, Inc., today announced a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types.
April 25, 2024
·
10 min read
Press Releases
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
January 31, 2025
·
4 min read
Press Releases
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Business
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery
Regeneron will use Mammoth Biosciences’ tiny Cas enzymes to deliver in vivo CRISPR-based gene editing therapies to tissues and cell types beyond the liver, the companies announced Thursday.
April 25, 2024
·
2 min read
·
Nick Paul Taylor
1 of 4,023
Next
